Abbas, Hadjan M.

HRN: 18-68-31  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2022
CEFTAZIDIME 1GM (VIAL)
05/06/2022
05/12/2022
IV
1 Gm
Q8H
T/C PTB Relapse; CAP-MR
Waiting Final Action 
05/06/2022
CEFTRIAXONE 1G (VIAL)
05/06/2022
05/12/2022
IV
2g
OD
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: